ENDRA Life Ownership

NDRA Stock  USD 6.05  0.21  3.60%   
Roughly 99.23 percent of ENDRA Life outstanding shares are held by general public with 0.28 (percent) owned by insiders and only 0.49 % by other corporate entities.
 
Shares in Circulation  
First Issued
2015-03-31
Previous Quarter
10.8 M
Current Value
246.8 K
Avarage Shares Outstanding
M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as ENDRA Life in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of ENDRA Life, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 27, 2024, Dividends Paid is expected to decline to 798.00. Dividend Yield is expected to grow at the current pace this year. The current year's Common Stock Shares Outstanding is expected to grow to about 9.5 M, whereas Net Loss is forecasted to decline to (12.5 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

ENDRA Stock Ownership Analysis

The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ENDRA Life Sciences recorded a loss per share of 2966.92. The entity had not issued any dividends in recent years. The firm had 1:35 split on the 7th of November 2024. ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. Endra Life operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To find out more about ENDRA Life Sciences contact Francois Michelon at 734 335 0468 or learn more at https://endrainc.com.
Besides selling stocks to institutional investors, ENDRA Life also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different ENDRA Life's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align ENDRA Life's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

ENDRA Life Quarterly Liabilities And Stockholders Equity

8.38 Million

ENDRA Life Insider Trades History

Less than 1% of ENDRA Life Sciences are currently held by insiders. Unlike ENDRA Life's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against ENDRA Life's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of ENDRA Life's insider trades
 
Yuan Drop
 
Covid

ENDRA Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as ENDRA Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ENDRA Life Sciences backward and forwards among themselves. ENDRA Life's institutional investor refers to the entity that pools money to purchase ENDRA Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Fmr Inc2024-06-30
0.0
Vanguard Group Inc2024-09-30
0.0
Geode Capital Management, Llc2024-09-30
0.0
Virtu Financial Llc2024-06-30
0.0
Xtx Topco Ltd2024-09-30
0.0
Two Sigma Securities, Llc2024-06-30
0.0
Northwestern Mutual Wealth Management Co2024-06-30
0.0
Hrt Financial Llc2024-06-30
329.6 K
Jane Street Group Llc2024-06-30
116.9 K
Ubs Group Ag2024-06-30
55.5 K
Susquehanna International Group, Llp2024-06-30
37.8 K
Note, although ENDRA Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ENDRA Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ENDRA Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ENDRA Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ENDRA Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ENDRA Life Outstanding Bonds

ENDRA Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ENDRA Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ENDRA bonds can be classified according to their maturity, which is the date when ENDRA Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

ENDRA Life Corporate Filings

8K
22nd of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
21st of November 2024
Other Reports
ViewVerify
10Q
19th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
15th of November 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.